Literature DB >> 25080500

Angiotensin II induces membrane trafficking of natively expressed transient receptor potential vanilloid type 4 channels in hypothalamic 4B cells.

Ashwini Saxena1, Martha Bachelor1, Yong H Park2, Flavia R Carreno3, T Prashant Nedungadi1, J Thomas Cunningham4.   

Abstract

Transient receptor potential vanilloid family type 4 (TRPV4) channels are expressed in central neuroendocrine neurons and have been shown to be polymodal in other systems. We previously reported that in the rodent, a model of dilutional hyponatremia associated with hepatic cirrhosis, TRPV4 expression is increased in lipid rafts from the hypothalamus and that this effect may be angiotensin dependent. In this study, we utilized the immortalized neuroendocrine rat hypothalamic 4B cell line to more directly test the effects of angiotensin II (ANG II) on TRPV4 expression and function. Our results demonstrate the expression of corticotropin-releasing factor (CRF) transcripts, for sex-determining region Y (SRY) (male genotype), arginine vasopressin (AVP), TRPV4, and ANG II type 1a and 1b receptor in 4B cells. After a 1-h incubation in ANG II (100 nM), 4B cells showed increased TRPV4 abundance in the plasma membrane fraction, and this effect was prevented by the ANG II type 1 receptor antagonist losartan (1 μM) and by a Src kinase inhibitor PP2 (10 μM). Ratiometric calcium imaging experiments demonstrated that ANG II incubation potentiated TRPV4 agonist (GSK 1016790A, 20 nM)-induced calcium influx (control 18.4 ± 2.8% n = 5 and ANG II 80.5 ± 2.4% n = 5). This ANG II-induced increase in calcium influx was also blocked by 1 μM losartan and 10 μM PP2 (losartan 26.4 ± 3.8% n = 5 and PP2 19.7 ± 3.9% n = 5). Our data suggests that ANG II can increase TRPV4 channel membrane expression in 4B cells through its action on AT1R involving a Src kinase pathway.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  4B; SRC kinase; SRY; TRPV4; angiotensin; hypothalamus

Mesh:

Substances:

Year:  2014        PMID: 25080500      PMCID: PMC4200379          DOI: 10.1152/ajpregu.00224.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  75 in total

1.  DNA methylation-mediated control of Sry gene expression in mouse gonadal development.

Authors:  Koichiro Nishino; Naoko Hattori; Satoshi Tanaka; Kunio Shiota
Journal:  J Biol Chem       Date:  2004-02-21       Impact factor: 5.157

2.  Glycosylation of the osmoresponsive transient receptor potential channel TRPV4 on Asn-651 influences membrane trafficking.

Authors:  Hongshi Xu; Yi Fu; Wei Tian; David M Cohen
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-20

Review 3.  Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.

Authors:  Y Saito; B C Berk
Journal:  J Mol Cell Cardiol       Date:  2001-01       Impact factor: 5.000

4.  Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase.

Authors:  Xiaochun Jin; Nemat Morsy; John Winston; Pankaj J Pasricha; Kennon Garrett; Hamid I Akbarali
Journal:  Am J Physiol Cell Physiol       Date:  2004-04-14       Impact factor: 4.249

5.  Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats.

Authors:  Joseph D Walch; Flávia Regina Carreño; J Thomas Cunningham
Journal:  Exp Physiol       Date:  2012-12-13       Impact factor: 2.969

6.  Impaired osmotic sensation in mice lacking TRPV4.

Authors:  Atsuko Mizuno; Naoko Matsumoto; Masashi Imai; Makoto Suzuki
Journal:  Am J Physiol Cell Physiol       Date:  2003-07       Impact factor: 4.249

Review 7.  Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms.

Authors:  Y-F Li; K P Patel
Journal:  Acta Physiol Scand       Date:  2003-01

8.  Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line.

Authors:  J Kasckow; J J Mulchahey; G Aguilera; M Pisarska; M Nikodemova; H-C Chen; J P Herman; E K Murphy; Y Liu; T A Rizvi; F M Dautzenberg; S Sheriff
Journal:  J Neuroendocrinol       Date:  2003-05       Impact factor: 3.627

9.  Perinuclear zone and diagonal band lesions enhance angiotensin responses of rat supraoptic neurons.

Authors:  J T Cunningham; R Nissen; L P Renaud
Journal:  Am J Physiol       Date:  1994-10

10.  Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis.

Authors:  S Gupta; T D Cheetham; H J Lambert; C Roberts; D Bourn; M G Coulthard; S G Ball
Journal:  Eur J Endocrinol       Date:  2009-06-19       Impact factor: 6.664

View more
  12 in total

1.  Augmented astrocyte microdomain Ca2+ dynamics and parenchymal arteriole tone in angiotensin II-infused hypertensive mice.

Authors:  Juan Ramiro Diaz; Ki Jung Kim; Michael W Brands; Jessica A Filosa
Journal:  Glia       Date:  2018-12-02       Impact factor: 7.452

2.  Brain-Derived Neurotrophic Factor and Supraoptic Vasopressin Neurons in Hyponatremia.

Authors:  Kirthikaa Balapattabi; Joel T Little; Martha Bachelor; J Thomas Cunningham
Journal:  Neuroendocrinology       Date:  2019-09-27       Impact factor: 4.914

3.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

4.  Role of angiotensin-converting enzyme 1 within the median preoptic nucleus following chronic intermittent hypoxia.

Authors:  Katelynn Faulk; Brent Shell; T Prashant Nedungadi; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-21       Impact factor: 3.619

5.  Sex Differences in the Regulation of Vasopressin and Oxytocin Secretion in Bile Duct Ligated Rats.

Authors:  Kirthikaa Balapattabi; Joel T Little; Martha E Bachelor; Rebecca L Cunningham; J Thomas Cunningham
Journal:  Neuroendocrinology       Date:  2020-04-24       Impact factor: 4.914

Review 6.  Cardiovascular Neuroendocrinology: Emerging Role for Neurohypophyseal Hormones in Pathophysiology.

Authors:  Ato O Aikins; Dianna H Nguyen; Obed Paundralingga; George E Farmer; Caroline Gusson Shimoura; Courtney Brock; J Thomas Cunningham
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

7.  Methamphetamine Activates Trace Amine Associated Receptor 1 to Regulate Astrocyte Excitatory Amino Acid Transporter-2 via Differential CREB Phosphorylation During HIV-Associated Neurocognitive Disorders.

Authors:  Irma E Cisneros; Anuja Ghorpade; Kathleen Borgmann
Journal:  Front Neurol       Date:  2020-11-25       Impact factor: 4.003

8.  Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium.

Authors:  Hiroshi Mihara; Nobuhiro Suzuki; Jibran Sualeh Muhammad; Sohachi Nanjo; Takayuki Ando; Haruka Fujinami; Shinya Kajiura; Ayumu Hosokawa; Toshiro Sugiyama
Journal:  Helicobacter       Date:  2016-09-30       Impact factor: 5.753

Review 9.  Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.

Authors:  Ewa Szczepanska-Sadowska; Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

10.  Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension.

Authors:  Jiaxi Xu; Srinivas Sriramula; Huijing Xia; Lisa Moreno-Walton; Frank Culicchia; Oliver Domenig; Marko Poglitsch; Eric Lazartigues
Journal:  Circ Res       Date:  2017-05-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.